You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Development of a novel highly effective influenza vaccine

    SBC: FLUGEN INC            Topic: NIAID

    DESCRIPTION provided by applicant Seasonal influenza flu virus an NIAID category C priority pathogen causes widespread infection resulting in at least million cases of severe illness and deaths worldwide Young children and elderly or immunocompromised individuals are typically at greater risk of severe illness or death from influenza Newly emerging strains can result ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  2. Development of Peptide Antibiotic Nucleic Acids

    SBC: NUBAD LLC            Topic: NIAID

    DESCRIPTION provided by applicant One of the challenges of research in infectious diseases is to find ways to use the increasing knowledge of the mechanisms underlying disease transformation and progression to develop novel therapeutic strategies for diseases such as increasing menace of bacterial infections Targeting specific RNA such as rRNA which are involved in proliferation and survival ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  3. STTR Phase I: 24x7 mobile wireless monitoring of patient's vitals to proactively manage disease recovery

    SBC: Argosy Omnimedia, Inc.            Topic: SH

    The broader impact/commercial potential of this Small Business Technology Transfer (STTR) Phase I project is found in the proposed technology development that facilitates direct, ubiquitous acquisition of key biomedical data, with little or no human intervention or introduction of errors, has the potential to reduce the costs of healthcare and to revolutionize healthcare delivery throughout our so ...

    STTR Phase I 2014 National Science Foundation
  4. STTR Phase I: The Development and Evaluation of an Intelligent Diabetes Self-Management Tool

    SBC: CADUCEUS INTELLIGENCE CORPORATION            Topic: SH

    The broader impact/commercial potential of this Small Business Technology Transfer (STTR) Phase I project is to develop an intelligent self-management tool for the 25 million diabetes patients in the US and the 200 million diabetes patients in the world. The proposed study is consonant with the vision of ?learning health system? from the Institute of Medicine in which appropriate interfaces should ...

    STTR Phase I 2014 National Science Foundation
  5. STTR Phase I: Ferrofluidic enclosures for enhanced control of thermal and magnetic fields in spin-stabilized atomic micro-devices

    SBC: COMMET LLC            Topic: EW

    The broader impact/commercial potential of this project is determined by new consumer products and new industries which would flourish on portable and reliable atomic clocks, gyroscopes, and magnetometers when they become available. Proposed compact thermal and magnetic enclosure reduces the most bulky part of such devices and provides an avenue for further miniaturization. A chip-scale atomic clo ...

    STTR Phase I 2014 National Science Foundation
  6. Inflatable Wing Morphing Aircraft Aeroservoelastic Control and Design Demonstration

    SBC: Intelligent Automation, Inc.            Topic: T401

    The role of UASs in the DoD has been continuously growing and is expected to show much higher growth rates in operations in the near future. A pressing need for such platforms is the need to be able to satisfy multiple mission objectives, without "compromising" on efficiency. This need is further exacerbated by increasing fuel prices, that dictates higher aerodynamic efficiencies across the comple ...

    STTR Phase I 2014 National Aeronautics and Space Administration
  7. Acousto-Optic Tunable Filter-Based Polarimetric Spectral Sensor With Progressive Algorithm For Material Analysis and Mapping

    SBC: BRIMROSE TECHNOLOGY CORP            Topic: T801

    The prevalence of off earth landing missions both proposed and undertaken has been steadily increasing. With the proposal of missions, not only to Mars, but also to comets, asteroids and outer planet moons, the ruggedness and robustness of equipment must meet the challenges of ever harsher environments. As a part of these missions, researchers wish to analyze the materials which make up the surfac ...

    STTR Phase I 2014 National Aeronautics and Space Administration
  8. Ultrastable and Compact Deep UV Laser Source for Raman Spectroscopy

    SBC: TIPD LLC            Topic: T801

    Deep-ultraviolet (UV) Raman spectroscopy is a powerful method to collect chemically specific information about complex samples because deep-UV (?? < 250 nm) excitation shows an over 200-fold greater efficiency compared to commonly used 785 nm excitation and has the ability to avoid fluorescence background in the Raman spectra. The availability of compact, robust, and reliable deep-UV laser source ...

    STTR Phase I 2014 National Aeronautics and Space Administration
  9. High Performance Nanolauncher

    SBC: Orbital Technologies Corporation            Topic: T101

    The proposed Low Cost Nanolauncher (LCN) is an upper stage using a new, inexpensive propulsion system. The Phase I program will combine several technologies with a simple design strategy to produce a flight-weight propulsion system that is easy to fabricate and operate. Self pressurizing propellants will minimize complexity of the propulsion system and vortex cold-wall technology will be used to ...

    STTR Phase I 2014 National Aeronautics and Space Administration
  10. Development of VPL Vaccine for RSV

    SBC: SIGMOVIR BIOSYSTEMS, INC.            Topic: NIAID

    Project Summary Human respiratory syncytial virus (RSV) is recognized as the single most important viral cause of acute respiratory disease in infants and young children worldwide. Elderly populations and immunocompromised individuals are also at significant risk for serious RSV disease. Despite this very substantial disease burden imposed by RSV worldwide, there are no vaccines available. Severa ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government